Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization

Vaccination development and production was an essential question for the prevention and global control of COVID-19. The strong support from governing authorities such as Operation Warp Speed and robust funding has led to the development and authorization of the tozinameran (BNT162b2) vaccine. The BN...

Descripción completa

Detalles Bibliográficos
Autores principales: Khehra, Nimrat, Padda, Inderbir, Jaferi, Urooj, Atwal, Harshan, Narain, Shreya, Parmar, Mayur S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184133/
https://www.ncbi.nlm.nih.gov/pubmed/34100150
http://dx.doi.org/10.1208/s12249-021-02058-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184133/
https://www.ncbi.nlm.nih.gov/pubmed/34100150
http://dx.doi.org/10.1208/s12249-021-02058-y

Ejemplares similares